Antioxidant Vitamins and Adrenocorticotrophic Hormone-Induced Hypertension in Rats

References

• Whitworth JA, Schyvens CG, Zhang Y, Mangos GJ, Kelly JJ. Glucocorticoid-induced hypertension: from mouse to man. Clin Exp Pharmacol Physiol 2001; 28: 993–996
   PubMed Web of Science ®Google Scholar
• Whitworth JA, Schyvens CG, Zhang Y, Andrews MC, Mangos GJ, Kelly J. The nitric oxide system in glucocorticoid-induced hypertension. J Hypertens 2002; 20: 1035–1043
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jang R, Mori TA, Croft KD, Schyvens CG, McKenzie KUS, Whitworth JA. The anti-oxidant tempol reverses and partially prevents adrenocorticotropic hormone-induced hypertension in the rat. J Hypertens 2003; 21: 1613–1618
   PubMedGoogle Scholar
• Zhang Y, Croft KD, Mori TA, Schyvens CG, McKenzie KUS, Whitworth JA. The anti-oxidant tempol prevents and partially reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 2004; 17: 260–265
   PubMed Web of Science ®Google Scholar
• Zhang Y, Chan MMK, Andrews MC, Mori TA, Croft KD, McKenzie KUS, Schyvens CG, Whitworth JA. Apocynin but not allopurinol prevents and reverses ACTH-induced hypertension in the rat. Am J Hypertens 2005; 18: 910–916
   PubMed Web of Science ®Google Scholar
• Hu L, Zhang Y, Lim PS, Miao Y, Tan C, McKenzie KUS, Schyvens CG, Whitworth JA. Apocynin but not L-arginine prevents and reverses dexamethasone-induced hypertension in the rat. Am J Hypertens 2006; 19: 413–418
   PubMed Web of Science ®Google Scholar
• Mondo CK, Zhang Y, Possamai V, Miao Y, Schyvens CG, McKenzie KUS, Hu L, Guo Z, Whitworth JA. N-acetylcysteine partially prevents but does not reverse ACTH-induced hypertension in the rat. Clin Exp Hypertens 2006; 28: 73–84
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Ni Z, Oveisi F, Trnavsky-Hobbs DL. Effect of antioxidant therapy on blood pressure and NO synthase expression in hypertension in rats. Hypertension 2000; 36: 957–964
   PubMed Web of Science ®Google Scholar
• Iuchi T, Akaike A, Mitsui T, Ohshima Y, Shintani Y, Azuma H, Matsumoto T. Glucocorticoid excess induces superoxide production in vascular endothelial cells and elicits vascular endothelial dysfunction. Circ Res 2003; 92: 81–87
   PubMed Web of Science ®Google Scholar
• Mangos GJ, Turner SW, Fraser TB, Whitworth JA. The role of corticosterone in corticotrophin (ACTH)-induced hypertension in the rat. J Hypertens 2000; 18: 1849–1855
   PubMed Web of Science ®Google Scholar
• Turner SW, Wen C, Li M, Whitworth JA. L-arginine prevents corticotropin-induced increases in blood pressure in the rat. Hypertension 1996; 27: 184–189
   PubMed Web of Science ®Google Scholar
• Wen C, Li M, Fraser T, Wang J, Turner SW, Whitworth JA. L-arginine partially reverses established adrenocorticotrophin-induced hypertension and nitric oxide deficiency in the rat. Blood Pressure 2000; 9: 298–304
   PubMed Web of Science ®Google Scholar
• Wen C, Li M, Whitworth JA. Role of nitric oxide in adrenocorticotrophin-induced hypertension: L-arginine effects reversed by N-nitro-L-arginine. Clin Exp Pharmacol Physiol 2000; 27: 887–890
   PubMed Web of Science ®Google Scholar
• Olsson B, Johansson M, Gabrielsson J, Bolme P. Pharmacokinetics and bioavailability of reduced and oxidized N-acetylcysteine. Eur J Clin Pharmacol 1988; 34: 77–82
   PubMed Web of Science ®Google Scholar
• Touyz RM. Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance?. Hypertension 2004; 44: 1–5
   PubMedGoogle Scholar
• McCall MR, Frei B. Can antioxidant vitamins materially reduce oxidative damage in humans?. Free Radic Biol Med 1999; 26: 1034–1053
   PubMed Web of Science ®Google Scholar
• Block G, Mangels AR, Norkus EP, Patterson BH, Levander OA, Taylor PR. Ascorbic acid status and subsequent diastolic and systolic blood pressure. Hypertension 2001; 37: 261–267
   PubMed Web of Science ®Google Scholar
• Chen J, He J, Hamm L, Batuman V, Whelton PK. Serum antioxidant vitamins and blood pressure in the United States population. Hypertension 2002; 40: 810–816
   PubMed Web of Science ®Google Scholar
• Heart Protection Study Collaboration Group. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 23–33
   PubMed Web of Science ®Google Scholar
• Padayatty SJ, Katz A, Wang Y, Eck P, Kwon O, Lee JH, Chen S, Corpe C, Dutta A, Dutta SK, Levine M. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr 2003; 22: 18–35
   PubMed Web of Science ®Google Scholar
• Houston MC. Nutraceuticals, vitamins, antioxidants, and minerals in the prevention and treatment of hypertension. Prog Cardiovasc Dis 2005; 47: 396–449
   PubMed Web of Science ®Google Scholar
• Brigelius-Flohe R, Traber MG. Vitamin E: function and metabolism. FASEB 1999; 13: 1145–1155
   PubMed Web of Science ®Google Scholar
• Hensley K, Benaksas EJ, Bolli R, Comp P, Grammas P, Hamdheydari L, Mou S, Pye QN, Stoddard MF, Wallis G, Williamson KS, West M, Wechter WJ, Floyd RA. New perspectives on Vitamin E: γ-tocopherol and carboxyethylhydroxychroman metabolites in biology and medicine. Free Rad Biol Med 2004; 36: 1–15
   PubMed Web of Science ®Google Scholar
• Moshage H, Kok B, Huizenga J, Jansen P. Nitrite and nitrate determination in plasma: a critical evaluation. Clin Chem 1995; 41: 892–896
   PubMed Web of Science ®Google Scholar
• Lee W, Hamernyik P, Hutchinson M, Raisys VA, Labbe RF. Ascorbic acid in lymphocytes: cell preparation and liquid-chromatography assay. Clin Chem 1982; 28: 2165–2169
   PubMed Web of Science ®Google Scholar
• Nilsson B, Johansson B, Jansson L, Holmberg L. Determination of plasma alpha-tocopherol by high-performance liquid chromatography. J Chromatogr 1978; 145: 169–172
   PubMed Web of Science ®Google Scholar
• Greggi Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res 2000; 41: 405–411
   PubMed Web of Science ®Google Scholar
• Lutz M, Cortez J, Vinet R. Effects of dietary fats, alpha-tocopherol and beta-carotene supplementation on aortic ring segment responses in the rat. Int J Vitam Nutr Res 1995; 65: 225–230
   PubMed Web of Science ®Google Scholar
• Clement M, Bourre JM. Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha- and gamma-tocopherol in nervous tissues, heart, liver and muscle of vitamin E-deficient rats. Biochim Biophys Acta 1997; 1334: 173–181
   PubMed Web of Science ®Google Scholar
• Seo MY, Lee SM. Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats. J Hepatol 2002; 36: 72–77
   PubMed Web of Science ®Google Scholar
• Chen X, Touyz RM, Park JB, Schiffrin EL. Antioxidant effects of vitamins C and E are associated with altered activation of vascular NADPH oxidase and superoxide dismutase in stroke-prone SHR. Hypertension 2001; 38: 606–611
   PubMed Web of Science ®Google Scholar
• Akpaffiong MJ, Taylor AA. Antihypertensive and vasodilator actions of antioxidants in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 1450–1460
   PubMed Web of Science ®Google Scholar
• Schafer SC, Wallerath T, Closs EI, Schmidt C, Schwarz PM, Forstermann U, Lehr HA. Dexamethasone suppresses eNOS and CAT-1 and induces oxidative stress in mouse resistance arterioles. Am J Physiol Heart Circ Physiol 2005; 288: H436–H444, Erratum in: Am J Physiol Heart Circ Physiol. 2005;289:H2752.
   PubMed Web of Science ®Google Scholar
• Kim MK, Sasaki S, Sasazuki S, Okubo S, Hayashi M, Tsugane S. Lack of long-term effect of vitamin C supplementation on blood pressure. Hypertension 2002; 40: 797–803
   PubMed Web of Science ®Google Scholar
• Saldeen T, Li D, Mehta JL. Differential effects of α- and γ-tocopherol on low-density lipoprotein oxidation, superoxide activity, platelet aggregation and arterial thrombogenesis. J Am Coll Cardiol 1999; 34: 1208–1215
   PubMed Web of Science ®Google Scholar
• Li D, Saldeen T, Romero F, Mehta JL. Relative effects of α- and γ-tocopherol on low-density lipoprotein oxidation and superoxide dismutase and nitric oxide synthase activity and protein expression in rats. J Cardiovasc Pharmacol Therapeut 1999; 4: 219–226
   PubMedGoogle Scholar
• Newaz MA, Nawal NN, Rohaizan CH, Muslim N, Gapor A. Alpha-tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats. Am J Hypertens 1999; 12: 839–844
   PubMed Web of Science ®Google Scholar
• Newaz MA, Nawal NN. Effect of alpha-tocopherol on lipid peroxidation and total antioxidant status in spontaneously hypertensive rats. Am J Hypertens 1998; 11: 1480–1485
   PubMed Web of Science ®Google Scholar
• Noguchi T, Ikeda K, Sasaki Y, Yamamoto J, Yamori Y. Effects of vitamin E and sesamin on hypertension and cerebral thrombogenesis in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 2004; 31(Suppl. 2)S24–S26
   PubMedGoogle Scholar
• Forde P, Scribner AW, Dial R, Loscalzo J, Trolliet MR. Prevention of hypertension and renal dysfunction in Dahl rats by alpha-tocopherol. J Cardiovasc Pharmacol 2003; 42: 82–88
   PubMed Web of Science ®Google Scholar
• Yusuf S, Dagenais G, Pogue J, Bosch J, Sleight P. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 154–160
   PubMed Web of Science ®Google Scholar
• Vivekananthan DP, Penn MS, Sapp SK, Hsu A, Topol EJ. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361: 2017–2023, Erratum in: Lancet2004 21;363:662.
   PubMed Web of Science ®Google Scholar
• Miller ER I, II, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142: 37–46
   PubMed Web of Science ®Google Scholar
• Maffei A, Poulet R, Vecchione C, Colella S, Fratta L, Frati G, Trimarco V, Trimarco B, Lembo G. Increased basal nitric oxide release despite enhanced free radical production in hypertension. J Hypertens 2002; 20: 1135–1142
   PubMed Web of Science ®Google Scholar